Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Condition: Breast Ductal Carcinoma in Situ Interventions: Drug: Low-dose tamoxifen; Radiation: Whole breast radiotherapy Sponsors: National Taiwan University Hospital; Tri-Service General Hospital; Koo Foundation Sun Yat-Sen Cancer Center; Kaohsiung Medical University; Kyoto University; Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials